INSIDE PHARMA Newsletter
INSIDE PHARMA is a science newsletter that mostly covers NDA, Accountability and Licensing Deals. We've analyzed 2 issues from the past year; the latest was published Oct 9, 2026.
In their own words: This Substack is about education in the Pharma supply chain and the industry that creates it. Massive reform is required and this gives subscribers the tools to drive it.
Visit INSIDE PHARMA ↗Main topics at a glance
Top 8 topics by mentions over the past year
2
Issues analyzed (12 mo)
30
Top topics
0
Brands mentioned
Oct 9, 2026
Latest issue
What INSIDE PHARMA writes about
Covid vaccines
1 mentionslicensing deals
1 mentionsBig Pharma
1 mentionsIND
1 mentionsprescription volume
1 mentionsprescription drug revenue
1 mentionsInside Pharma
1 mentionsblockbuster drugs
1 mentionsattrition rates
1 mentionsoutsourcing
1 mentionsBIO/QLS
1 mentionspharma companies
1 mentionsgeneric medicines
1 mentionsdevelopment candidates
1 mentionspharmaceutical industry
1 mentionsdependable supply
1 mentionsvalley of death
1 mentionsoversight
1 mentionspatient supply
1 mentionscontractor failures
1 mentionsmanufacturing expertise
1 mentionsNDA
1 mentionspatent protection
1 mentionsdrug approval
1 mentionspatent cliff
1 mentionssupply chain resilience
1 mentionsaccountability
1 mentionsnon-clinical supply chain
1 mentionsbusiness model
1 mentionsclinical supply chain
1 mentionsRecent issues of INSIDE PHARMA
More Science newsletters
Best Science newsletters →Explore more:Newsletter directory ·Trending Topics ·Weekly Insights